[go: up one dir, main page]

HK1226485A1 - Methods of determining response to therapy - Google Patents

Methods of determining response to therapy Download PDF

Info

Publication number
HK1226485A1
HK1226485A1 HK16114757.6A HK16114757A HK1226485A1 HK 1226485 A1 HK1226485 A1 HK 1226485A1 HK 16114757 A HK16114757 A HK 16114757A HK 1226485 A1 HK1226485 A1 HK 1226485A1
Authority
HK
Hong Kong
Prior art keywords
therapy
methods
determining response
response
determining
Prior art date
Application number
HK16114757.6A
Other languages
Chinese (zh)
Inventor
Jonathan Rubin
Yaron DANIELY
Johanna SCHUMANN
Original Assignee
Alcobra Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcobra Ltd. filed Critical Alcobra Ltd.
Publication of HK1226485A1 publication Critical patent/HK1226485A1/en

Links

HK16114757.6A 2013-09-09 2014-09-09 Methods of determining response to therapy HK1226485A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/875,384 2013-09-09
US14/038,258 2013-09-26
US61/991,351 2014-05-09

Publications (1)

Publication Number Publication Date
HK1226485A1 true HK1226485A1 (en) 2017-09-29

Family

ID=

Similar Documents

Publication Publication Date Title
IL287516A (en) Therapeutic uses of empagliflozin
EP3024456A4 (en) Combinatorial methods to improve the therapeutic benefit of bisantrene
IL244791A0 (en) Methods of host cell modification
EP3080100A4 (en) Inhibitors of lysine specific demethylase-1
IL241101A0 (en) Therapeutic uses of empagliflozin
EP2992089A4 (en) Use of anti-cd47 agents to enhance immunization
EP3065875A4 (en) Bioprinter and methods of using same
EP3030302A4 (en) Improvements to flow therapy
IL241102A0 (en) Therapeutic uses of empagliflozin
EP3041569A4 (en) Detection of reduced-control cardiac zones
EP3020828A4 (en) Method of predicting response of cancer to treatment
PL2981271T3 (en) Therapeutic uses of empagliflozin
IL244453A0 (en) Methods of determining response to therapy
EP3055281A4 (en) Preparation of hydroxy-benzylbenzene derivatives
EP3054974A4 (en) Glycan-interacting compounds and methods of use
EP3072910A4 (en) Derivative of styrene-maleic acid copolymer
EP3049079A4 (en) Solid forms of ceftolozane
EP3027182A4 (en) Novel copper-cysteamine and methods of use
EP2994124A4 (en) INHIBITORS OF METALLO-ß-LACTAMASE-ENZYMES
EP3008213A4 (en) Detection of protein to protein interactions
EP3052656A4 (en) Methods of determining polymorphisms
EP2959460A4 (en) System to accept an item of value
EP2968996A4 (en) Methods of monitoring for adherence to aripiprazole therapy
EP3049378A4 (en) Preparation of radioiodinated 3-fluoropropyl-nor-beta-cit
EP2786402B8 (en) Method of mechanosynthetic manufacture